Vera Therapeutics, Inc. · NASDAQ:VERA
Fordyce Marshall sold 46,250 Vera Therapeutics, Inc. shares (Form 4/A)
Traded Jul 7, 2026 · Filed Aug 12, 2026
On Jul 7, 2026, Fordyce Marshall (Director, PRESIDENT AND CEO) sold 46,250 Vera Therapeutics, Inc. shares at an average US$42.29 for US$1.96M under a trading plan, leaving 235,244 shares. Filed Aug 12, 2026 (Form 4/A).
- Sold
- 46,250 shares
- Price
- US$42.29 average (US$40.78 to US$43.59)
- Value
- US$1.96M
- Holding after
- 235,244 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, PRESIDENT AND CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | Class A Common Stock | Option exercise | 46,250 | US$2.90 | 281,494 | Direct |
| Jul 7, 2026 | Class A Common Stock | Sale | 1,000 | US$40.78 | 280,494 | Direct |
| Jul 7, 2026 | Class A Common Stock | Sale | 32,550 | US$42.07 | 247,944 | Direct |
| Jul 7, 2026 | Class A Common Stock | Sale | 10,500 | US$42.86 | 237,444 | Direct |
| Jul 7, 2026 | Class A Common Stock | Sale | 2,200 | US$43.59 | 235,244 | Direct |
Source
Related
- Vera Therapeutics, Inc.
- Fordyce Marshall
- Vera Therapeutics, Inc. shareholders
- Form 4 · Fordyce Marshall · Sep 17, 2026
- Form 4 · Fordyce Marshall · Sep 4, 2026
- Form 4/A · Fordyce Marshall · Aug 12, 2026
- Form 4/A · Fordyce Marshall · Aug 12, 2026
- Form 4 · Fordyce Marshall · Jun 24, 2026
- Form 4 · Young Joseph R · Sep 14, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Boman Nancy Lee · Aug 5, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 30, 2026